Case of cetuximab-induced disseminated necrotic and maculopapular eruptions: Involvement of an epidermal growth factor receptor inhibitor with epidermal necrosis

J Dermatol. 2018 Jan;45(1):e3-e4. doi: 10.1111/1346-8138.14070. Epub 2017 Oct 3.

Authors

Takeshi Namiki¹, Chika Omigawa¹, Kohei Nojima¹, Takuya Wakasa¹, Shown Tokoro¹, Takaaki Hanafusa¹, Keiko Miura², Hiroo Yokozeki¹

Affiliations

¹ Department of Dermatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
² Department of Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

PMID: 28971521
DOI: 10.1111/1346-8138.14070

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents, Immunological / adverse effects*
Cetuximab / adverse effects*
Colonic Neoplasms / drug therapy
Drug Eruptions / etiology*
Drug Eruptions / pathology
ErbB Receptors / antagonists & inhibitors
Female
Humans
Necrosis / chemically induced
Necrosis / pathology
Skin / drug effects
Skin / pathology*

Substances

Antineoplastic Agents, Immunological
EGFR protein, human
ErbB Receptors
Cetuximab